Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
139.00
+12.50 (9.88%)
Apr 29, 2026, 1:30 PM CST
TPEX:3218 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,718 | 12,370 | 16,945 | 23,469 | 23,859 | 21,543 | Upgrade
|
| Market Cap Growth | -38.89% | -27.00% | -27.80% | -1.64% | 10.75% | 18.41% | Upgrade
|
| Enterprise Value | 9,814 | 11,792 | 16,391 | 23,062 | 23,751 | 21,599 | Upgrade
|
| Last Close Price | 126.50 | 137.83 | 182.60 | 246.09 | 246.00 | 217.97 | Upgrade
|
| PE Ratio | 10.32 | 11.86 | 15.92 | 22.46 | 28.05 | 36.18 | Upgrade
|
| Forward PE | 9.39 | 12.81 | 12.81 | 12.81 | 12.81 | 12.81 | Upgrade
|
| PS Ratio | 2.55 | 2.94 | 4.01 | 5.75 | 6.83 | 8.19 | Upgrade
|
| PB Ratio | 2.58 | 2.97 | 4.51 | 7.02 | 8.43 | 9.25 | Upgrade
|
| P/TBV Ratio | 2.67 | 3.08 | 4.71 | 7.44 | 9.04 | 9.97 | Upgrade
|
| P/FCF Ratio | 9.71 | 11.21 | 13.69 | 21.71 | 30.65 | 36.68 | Upgrade
|
| P/OCF Ratio | 6.43 | 7.42 | 10.13 | 15.11 | 18.81 | 23.63 | Upgrade
|
| EV/Sales Ratio | 2.33 | 2.81 | 3.88 | 5.65 | 6.80 | 8.21 | Upgrade
|
| EV/EBITDA Ratio | 5.11 | 6.82 | 9.43 | 14.49 | 18.34 | 22.91 | Upgrade
|
| EV/EBIT Ratio | 7.11 | 8.54 | 11.73 | 17.58 | 21.97 | 28.10 | Upgrade
|
| EV/FCF Ratio | 8.89 | 10.68 | 13.25 | 21.33 | 30.51 | 36.77 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.26 | 0.28 | 0.23 | 0.28 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 0.55 | 0.55 | 0.55 | 0.44 | 0.54 | 0.71 | Upgrade
|
| Debt / FCF Ratio | 0.96 | 0.96 | 0.85 | 0.72 | 1.01 | 1.31 | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.25 | -0.23 | -0.26 | -0.17 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.60 | -0.60 | -0.50 | -0.54 | -0.38 | -0.29 | Upgrade
|
| Net Debt / FCF Ratio | -0.94 | -0.94 | -0.70 | -0.80 | -0.64 | -0.46 | Upgrade
|
| Asset Turnover | 0.71 | 0.71 | 0.78 | 0.85 | 0.85 | 0.76 | Upgrade
|
| Inventory Turnover | 5.80 | 5.80 | 5.80 | 6.26 | 7.89 | 11.17 | Upgrade
|
| Quick Ratio | 2.55 | 2.55 | 2.29 | 2.18 | 2.05 | 2.17 | Upgrade
|
| Current Ratio | 2.92 | 2.92 | 2.61 | 2.52 | 2.37 | 2.43 | Upgrade
|
| Return on Equity (ROE) | 26.65% | 26.65% | 29.59% | 34.48% | 33.66% | 27.96% | Upgrade
|
| Return on Assets (ROA) | 14.55% | 14.55% | 16.04% | 17.02% | 16.37% | 13.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 34.57% | 35.99% | 41.46% | 43.98% | 39.16% | 33.87% | Upgrade
|
| Return on Capital Employed (ROCE) | 27.30% | 27.30% | 29.90% | 31.90% | 30.10% | 25.50% | Upgrade
|
| Earnings Yield | 9.73% | 8.43% | 6.28% | 4.45% | 3.56% | 2.76% | Upgrade
|
| FCF Yield | 10.30% | 8.92% | 7.30% | 4.61% | 3.26% | 2.73% | Upgrade
|
| Dividend Yield | 6.28% | 5.62% | 4.11% | 2.84% | 2.30% | 2.06% | Upgrade
|
| Payout Ratio | 60.95% | 60.95% | 55.70% | 45.89% | 44.75% | 53.70% | Upgrade
|
| Buyback Yield / Dilution | -0.10% | -0.10% | -0.08% | -0.04% | -0.03% | 0.03% | Upgrade
|
| Total Shareholder Return | 6.18% | 5.53% | 4.03% | 2.80% | 2.27% | 2.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.